Sex differences in Alzheimer's disease (AD) progression offer insights into pathogenesis and clinical management. White matter (WM) amplitude of low-frequency fluctuation (ALFF), reflecting neural activity, represents a potential disease biomarker.
Objective
To explore whether there are sex differences in regional WM ALFF among AD patients, amnestic mild cognitive impairment (aMCI) patients, and healthy controls (HCs), how it is related to cognitive performance, and whether it can be used for disease classification.
Methods
Resting-state functional magnetic resonance images and cognitive assessments were obtained from 85 AD (36 female), 52 aMCI (23 female), and 78 HCs (43 female). Two-way ANOVA examined group × sex interactions for regional WM ALFF and cognitive scores. WM ALFF-cognition correlations and support vector machine diagnostic accuracy were evaluated.
Results
Sex × group interaction effects on WM ALFF were detected in the right superior longitudinal fasciculus (F = 20.08, pFDR_corrected < 0.001), left superior longitudinal fasciculus (F = 5.45, pGRF_corrected < 0.001) and right inferior longitudinal fasciculus (F = 6.00, pGRF_corrected = 0.001). These WM ALFF values positively correlated with different cognitive performance between sexes. The support vector machine learning best differentiated aMCI from AD in the full cohort and males (accuracy = 75%), and HCs from aMCI in females (accuracy = 93%).
Conclusions
Sex differences in regional WM ALFF during AD progression are associated with cognitive performance and can be utilized for disease classification.
MarfanyASierraCCamafortM, et al.High blood pressure, Alzheimer disease and antihypertensive treatment. Panminerva Med2018; 60: 8–16.
2.
GozdasEFingerhutHChromikLC, et al.Focal white matter disruptions along the cingulum tract explain cognitive decline in amnestic mild cognitive impairment (aMCI). Sci Rep2020; 10: 10213.
3.
PetersenRCCaraccioloBBrayneC, et al.Mild cognitive impairment: a concept in evolution. J Intern Med2014; 275: 214–228.
4.
PetersenRC. Mild cognitive impairment as a diagnostic entity. J Intern Med2004; 256: 183–194.
5.
KovacsGGAlafuzoffIAl-SarrajS, et al.Mixed brain pathologies in dementia: the BrainNet Europe consortium experience. Dement Geriatr Cogn Disord2008; 26: 343–350.
6.
FarrerLACupplesLAHainesJL, et al.Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer disease meta analysis consortium. JAMA1997; 278: 1349–1356.
7.
LyuDLiTLyuX. Resting-state functional reorganisation in Alzheimer's disease and amnestic mild cognitive impairment: protocol for a systematic review and meta-analysis. BMJ Open2021; 11: e049798.
8.
BuckleyRFMorminoECAmariglioRE, et al.Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: findings from three well-characterized cohorts. Alzheimers Dement2018; 14: 1193–1203.
9.
OveisgharanSArvanitakisZYuL, et al.Sex differences in Alzheimer's disease and common neuropathologies of aging. Acta Neuropathol2018; 136: 887–900.
LiHHuangZGaoZ, et al.Sex difference in general cognition associated with coupling of whole-brain functional connectivity strength to cerebral blood flow changes during Alzheimer's disease progression. Neuroscience2023; 509: 187–200.
12.
WilliamsonJYabluchanskiyAMukliP, et al.Sex differences in brain functional connectivity of hippocampus in mild cognitive impairment. Front Aging Neurosci2022; 14: 959394.
13.
ZangYFHeYZhuCZ, et al.Altered baseline brain activity in children with ADHD revealed by resting-state functional MRI. Brain Dev2007; 29: 83–91.
14.
LiCLiuCYinX, et al.Frequency-dependent changes in the amplitude of low-frequency fluctuations in subcortical ischemic vascular disease (SIVD): a resting-state fMRI study. Behav Brain Res2014; 274: 205–210.
15.
HuangLHuangGDingQ, et al.Amplitude of low-frequency fluctuation (ALFF) alterations in adults with subthreshold depression after physical exercise: a resting-state fMRI study. J Affect Disord2021; 295: 1057–1065.
16.
WuZLuoQWuH, et al.Amplitude of low-frequency oscillations in major depressive disorder with childhood trauma. Front Psychiatry2020; 11: 596337.
17.
WangJChenHLiangH, et al.Low-frequency fluctuations amplitude signals exhibit abnormalities of intrinsic brain activities and reflect cognitive impairment in leukoaraiosis patients. Med Sci Monit2019; 25: 5219–5228.
18.
FoxMDRaichleME. Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging. Nat Rev Neurosci2007; 8: 700–711.
19.
ZhangDRaichleME. Disease and the brain's dark energy. Nat Rev Neurol2010; 6: 15–28.
20.
LiuXWangSZhangX, et al.Abnormal amplitude of low-frequency fluctuations of intrinsic brain activity in Alzheimer's disease. J Alzheimers Dis2014; 40: 387–397.
21.
JiGJLiaoWChenFF, et al.Low-frequency blood oxygen level-dependent fluctuations in the brain white matter: more than just noise. Sci Bull (Beijing)2017; 62: 656–657.
22.
DingZHuangYBaileySK, et al.Detection of synchronous brain activity in white matter tracts at rest and under functional loading. Proc Natl Acad Sci U S A2018; 115: 595–600.
23.
GawrylukJRELMD'ArcyRC. Does functional MRI detect activation in white matter? A review of emerging evidence, issues, and future directions. Front Neurosci2014; 8: 239.
24.
van OschMJTeeuwisseWMvan WalderveenMA, et al.Can arterial spin labeling detect white matter perfusion signal?Magn Reson Med2009; 62: 165–173.
25.
AslanSHuangHUhJ, et al.White matter cerebral blood flow is inversely correlated with structural and functional connectivity in the human brain. Neuroimage2011; 56: 1145–1153.
26.
MakedonovIChenJJMasellisM, et al.Physiological fluctuations in white matter are increased in Alzheimer's disease and correlate with neuroimaging and cognitive biomarkers. Neurobiol Aging2016; 37: 12–18.
27.
YanYWuYXiaoG, et al.White matter changes as an independent predictor of Alzheimer's disease. J Alzheimers Dis2023; 93: 1443–1455.
28.
JiGJRenCLiY, et al.Regional and network properties of white matter function in Parkinson's disease. Hum Brain Mapp2019; 40: 1253–1263.
29.
ProvenzanoFAMuraskinJTostoG, et al.White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease?JAMA Neurol2013; 70: 455–461.
30.
Graff-RadfordJArenaza-UrquijoEMKnopmanDS, et al.White matter hyperintensities: relationship to amyloid and tau burden. Brain2019; 142: 2483–2491.
31.
GaoYSenguptaALiM, et al.Functional connectivity of white matter as a biomarker of cognitive decline in Alzheimer's disease. PloS One2020; 15: e0240513.
32.
ZhangZLiuYJiangT, et al.Altered spontaneous activity in Alzheimer's disease and mild cognitive impairment revealed by regional homogeneity. Neuroimage2012; 59: 1429–1440.
33.
McKhannGDrachmanDFolsteinM, et al.Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology1984; 34: 939–944.
34.
McKhannGMKnopmanDSChertkowH, et al.The diagnosis of dementia due to Alzheimer's disease: recommendations from the national institute on aging-Alzheimer's association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement2011; 7: 263–269.
35.
DuboisBFeldmanHHJacovaC, et al.Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol2007; 6: 734–746.
36.
LiXWangHTianY, et al.Impaired white matter connections of the limbic system networks associated with impaired emotional memory in Alzheimer's disease. Front Aging Neurosci2016; 8: 250.
37.
LiXLiXChenS, et al.Effect of emotional enhancement of memory on recollection process in young adults: the influence factors and neural mechanisms. Brain Imaging Behav2020; 14: 119–129.
38.
ZouQHZhuCZYangY, et al.An improved approach to detection of amplitude of low-frequency fluctuation (ALFF) for resting-state fMRI: fractional ALFF. J Neurosci Methods2008; 172: 137–141.
39.
YangCZhangWYaoL, et al.Functional alterations of white matter in chronic never-treated and treated schizophrenia patients. J Magn Reson Imaging2020; 52: 752–763.
40.
GuoQDuanJCaiS, et al.Desynchronized white matter function and structure in drug-naive first-episode major depressive disorder patients. Front Psychiatry2022; 13: 1082052.
41.
PiroozniaMDengY. SVM classifier - a comprehensive Java interface for support vector machine classification of microarray data. BMC Bioinformatics2006; 7: S25.
42.
WuYWuXGaoL, et al.Abnormal functional connectivity of thalamic subdivisions in Alzheimer's disease: a functional magnetic resonance imaging study. Neuroscience2022; 496: 73–82.
43.
ZhongSLouJMaK, et al.Disentangling in-vivo microstructural changes of white and gray matter in mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis. Brain Imaging Behav2023; 17: 764–777.
44.
LatiniFMårtenssonJLarssonEM, et al.Segmentation of the inferior longitudinal fasciculus in the human brain: a white matter dissection and diffusion tensor tractography study. Brain Res2017; 1675: 102–115.
45.
HerbetGZemmouraIDuffauH. Functional anatomy of the inferior longitudinal fasciculus: from historical reports to current hypotheses. Front Neuroanat2018; 12: 77.
46.
QinLGuoZMcClureMA, et al.White matter changes from mild cognitive impairment to Alzheimer's disease: a meta-analysis. Acta Neurol Belg2021; 121: 1435–1447.
47.
ZhuQYBiSWYaoXT, et al.Disruption of thalamic connectivity in Alzheimer's disease: a diffusion tensor imaging study. Metab Brain Dis2015; 30: 1295–1308.
48.
Van der WerfYDJollesJWitterMP, et al.Contributions of thalamic nuclei to declarative memory functioning. Cortex2003; 39: 1047–1062.
49.
FlorescoSBGraceAA. Gating of hippocampal-evoked activity in prefrontal cortical neurons by inputs from the mediodorsal thalamus and ventral tegmental area. J Neurosci2003; 23: 3930–3943.
50.
ConnerAKBriggsRGSaliG, et al.A connectomic atlas of the human cerebrum-chapter 13: tractographic description of the inferior fronto-occipital fasciculus. Oper Neurosurg (Hagerstown)2018; 15: S436–S443.
51.
DuffauH. The anatomo-functional connectivity of language revisited. New insights provided by electrostimulation and tractography. Neuropsychologia2008; 46: 927–934.
52.
AlmairacFHerbetGMoritz-GasserS, et al.The left inferior fronto-occipital fasciculus subserves language semantics: a multilevel lesion study. Brain Struct Funct2015; 220: 1983–1995.
53.
ZhangYZChangCWeiXE, et al.Comparison of diffusion tensor image study in association fiber tracts among normal, amnestic mild cognitive impairment, and Alzheimer's patients. Neurol India2011; 59: 168–173.
54.
ComptonJvan AmelsvoortTMurphyD. Mood, cognition and Alzheimer's disease. Best Pract Res Clin Obstet Gynaecol2002; 16: 357–370.
55.
HaraYWatersEMMcEwenBS, et al.Estrogen effects on cognitive and synaptic health over the lifecourse. Physiol Rev2015; 95: 785–807.
56.
GreeneRA. Estrogen and cerebral blood flow: a mechanism to explain the impact of estrogen on the incidence and treatment of Alzheimer's disease. Int J Fertil Womens Med2000; 45: 253–257.
57.
SternY. Cognitive reserve in ageing and Alzheimer's disease. Lancet Neurol2012; 11: 1006–1012.
58.
YasunoFMinamiHHattoriH. Interaction effect of Alzheimer's disease pathology and education, occupation, and socioeconomic status as a proxy for cognitive reserve on cognitive performance: in vivo positron emission tomography study. Psychogeriatrics2020; 20: 585–593.
59.
KoshiyamaDFukunagaMOkadaN, et al.Association between the superior longitudinal fasciculus and perceptual organization and working memory: a diffusion tensor imaging study. Neurosci Lett2020; 738: 135349.
60.
MadhavanKMMcQueenyTHoweSR, et al.Superior longitudinal fasciculus and language functioning in healthy aging. Brain Res2014; 1562: 11–22.
61.
WolfersTOnninkAMZwiersMP, et al.Lower white matter microstructure in the superior longitudinal fasciculus is associated with increased response time variability in adults with attention-deficit/ hyperactivity disorder. J Psychiatry Neurosci2015; 40: 344–351.
62.
HallerSMontandonMLRodriguezC, et al.Amyloid load, hippocampal volume loss, and diffusion tensor imaging changes in early phases of brain aging. Front Neurosci2019; 13: 1228.
63.
AgostaFPievaniMSalaS, et al.White matter damage in Alzheimer disease and its relationship to gray matter atrophy. Radiology2011; 258: 853–863.
64.
BrickmanAMProvenzanoFAMuraskinJ, et al.Regional white matter hyperintensity volume, not hippocampal atrophy, predicts incident Alzheimer disease in the community. Arch Neurol2012; 69: 1621–1627.
65.
ZhuangLSachdevPSTrollorJN, et al.Microstructural white matter changes, not hippocampal atrophy, detect early amnestic mild cognitive impairment. PloS One2013; 8: e58887.
